期刊文献+

Gail乳腺癌评估模型在乳腺癌社区预防的应用 被引量:7

Application of Gail model for breast cancer assessment in breast cancer prevention in the community
原文传递
导出
摘要 目的:探讨Gail乳腺癌评估模型在社区预防乳腺癌的应用。方法:于2009年1月~2011年4月对深圳市宝安区729名35~65岁社区妇女进行乳腺保健教育,使用Gail乳腺癌评估模型评估乳腺癌发病风险,实施乳腺临床检查、乳腺B超检查或/和乳腺X线检查,并进行追踪随访1年,分析和总结Gail乳腺癌评估模型在社区预防乳腺癌中的作用。结果:729名妇女中筛查出高风险274人,低风险455人;高风险人群乳腺疾病检出率64.23%,低风险人群乳腺疾病检出率63.30%,两组检出率差异无统计学意义(P>0.05);高风险组乳腺肿块和乳腺癌的检出率高于低风险组,差异有统计学意义(P<0.05)。结论:进行乳腺癌发病风险评估,从而有针对性地对重点人群进行干预,Gail乳腺癌评估模型在社区乳腺癌的预防中有一定的参考价值。 Objective:To explore the application of Gail model for breast cancer assessment in breast cancer prevention in the community.Methods:Breast health education was conducted among 729 women aged 35-65 years old in Baoan district of Shenzhen city from January 2009 to April 2011,Gail model for breast cancer assessment was used to evaluate the risk of breast cancer.Clinical breast examination,breast type-B ultrasound and/or breast X-ray examination were performed and all the women were followed up for one year.The function of Gail model for breast cancer assessment in breast cancer prevention in the community was analyzed and summarized.Results:Among 729 women,274 women were found as high risk population,and 455 women were found as low risk population.The detection rates of breast diseases in high risk population and low risk population were 64.23% and 63.30%,respectively,there was no statistically significant difference between the two groups(P0.05).The detection rates of breast mass and breast cancer in high risk group were statistically significantly higher than those in low risk group(P0.05).Conclusion:The risk assessment for breast cancer is helpful to intervene the targeted population.Gail model for breast cancer assessment has a certain reference value in breast cancer prevention in the community.
出处 《中国妇幼保健》 CAS 北大核心 2013年第3期414-417,共4页 Maternal and Child Health Care of China
基金 深圳市科技计划项目〔200903165〕
关键词 乳腺癌 社区 筛查 Gail模型 Breast cancer Community Screening Gail model
  • 相关文献

参考文献6

二级参考文献194

  • 1吴家刚,方亚.女性乳腺癌危险因素研究进展[J].医学与社会,2005,18(1):16-18. 被引量:33
  • 2吴家刚,方亚.人工流产与女性乳腺癌关系的Meta分析[J].中国医院统计,2004,11(4):332-334. 被引量:10
  • 3闻芝梅 陈君石(译).现代营养学[M].北京:人民卫生出版社,1998..
  • 4葛可佑.中国八省居民健康与营养状况[M].北京:科学技术出版社,1998.11-12,38-39.
  • 5葛可佑 翟凤英 金水高.中国八省居民健康与营养状况[M].北京:科学技术出版社,1998.15-20.
  • 6[4]Deena Damsky Dell,MSN,RN,et al.Spread the Word About Breast Cancer[J].Nursing,2005,35(10):56-63.
  • 7[6]Colditz GA,Rosner B.Cumulative risk of breast cancer to age 70 years according to risk factor status:data from file Nurses' Health Study[J].Am J Epidemiol,2000,152(10):950-964.
  • 8[7]K McPherson,C M Steel,J M Dixon.ABC of breast cancer:Breast cancer-epidemiology,risk factors,and genetics[J].BMJ,2000,321(7261):624-628.
  • 9[13]Okobia MN,Bunker CH.Epidemiological risk factors for breast cancer-a review[J].Nigerian Journal of Clinical Practice,2005,8(1):35-42.
  • 10[14]Kabat,Geoffrey C.O'Leary,Erin S,Gammon,Marilie D,et al.Estrogen Metabolism and Breast Cancer[J].Epidemiology,2006,17(1):80-88.

共引文献91

同被引文献71

  • 1马恒敏,王圣芳,冷玲,朱峰,李琰琰,史思达,左文述,王家林.山东省肥城市2008-2011年乳腺癌筛查结果分析[J].中华肿瘤防治杂志,2013,20(2):88-92. 被引量:11
  • 2王盈.乳腺癌高危女性的风险评估和预防策略[J].世界临床药物,2004,25(9):561-563. 被引量:1
  • 3王琦.9种基本中医体质类型的分类及其诊断表述依据[J].北京中医药大学学报,2005,28(4):1-8. 被引量:2190
  • 4邵志敏,沈镇宙,徐兵河,主编.乳腺肿瘤学[M].上海:复旦大学出版社,2013: 24-25.
  • 5Siegel R, Ma J, ZouZ,et al. Cancer statistics,2014[ J]. CACancer J Clin, 2014,64(1):9-29.
  • 6Cuzick J, Sestak I,Bonanni B, et al. Selective oestrogenreceptor modulators in prevention of breast cancer : an updatedmeta-analysis of individual participant data[ J]. Lancet, 2013,381(9880):1827-1834.
  • 7Goss PE, Ingle JN, Al6s-Martlnez JE, et al. Exemestane forbreast-cancer prevention in postmenopausal women [ J ]. N EnglJ Med, 2011,364(25) :2381-2391.
  • 8Cuzick J, Sestak I, Forbes JF, et al. Anastrozole for preventionof breast cancer in high-risk postmenopausal women (IBIS- H ):an international, double-blind, randomised placebo-controlledtrial[J]. Lancet,2014,383(9922) : 1041-1048.
  • 9Moyer VA, U.S. Preventive Services Task Force. Medicationsto decrease the risk for breast cancer in women:recommendations from the U. S. Preventive Services Task Forcerecommendation statement [J]. Ann Intern Med, 2013,159(10):698-708.
  • 10Visvanathan K, Hurley P, Bantug E, et al. Use ofpharmacologic interventions for breast cancer risk reduction :American Society of Clinical Oncology clinical practiceguideline[J]. J Clin Oncol,2013,31(23) =2942-2962.

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部